Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Kikuchi-Fujimoto disease (KFD) is a benign and self-limited disorder, characterized by regional cervical lymphadenopathy with tenderness, usually accompanied with mild fever and night sweats. Less frequent symptoms include weight loss, nausea, vomiting, sore throat.
Biomarker and diagnostic research for Kikuchi-Fujimoto disease has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for Kikuchi-Fujimoto disease.
143 publications have been identified in PubMed for Kikuchi-Fujimoto disease. Research spans Case Report / Case Series (60%), Review / Meta-Analysis (10%), and Epidemiology / Natural History (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 86 | 60% |
Data assembled from 3 of 12 sources · Last updated Nov 4, 2026, 6:05 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Kikuchi-Fujimoto disease
15 |
10% |
Disease patterns and progression | 12 | 8% |
Testing and diagnosis research | 11 | 8% |
Laboratory research | 9 | 6% |
Other research | 7 | 5% |
Clinical study results | 3 | 2% |
Mustafa M (2026). [PMID: 41588953](https://pubmed.ncbi.nlm.nih.gov/41588953/). *Curr Rheumatol Rev*. [Case Report / Case Series]
Bhasale S (2026). [PMID: 41943403](https://pubmed.ncbi.nlm.nih.gov/41943403/). *Ann Afr Med*. [Diagnostic / Biomarker]
Yildiz S (2026). [PMID: 40966742](https://pubmed.ncbi.nlm.nih.gov/40966742/). *Pediatr Infect Dis J*. [Diagnostic / Biomarker]
Akhondi A (2026). [PMID: 42060031](https://pubmed.ncbi.nlm.nih.gov/42060031/). *Clin Rheumatol*. [Review / Meta-Analysis]
Ujupi D (2026). [PMID: 41923504](https://pubmed.ncbi.nlm.nih.gov/41923504/). *Rev Med Suisse*. [Review / Meta-Analysis]
Asano S (2026). [PMID: 42055669](https://pubmed.ncbi.nlm.nih.gov/42055669/). *J Clin Exp Hematop*. [Basic Science / Preclinical]
Kim GH (2026). [PMID: 42129787](https://pubmed.ncbi.nlm.nih.gov/42129787/). *Biomed Eng Online*. [Diagnostic / Biomarker]
Zhong P (2026). [PMID: 41684139](https://pubmed.ncbi.nlm.nih.gov/41684139/). *Immun Inflamm Dis*. [Epidemiology / Natural History]
Matsumoto S (2026). [PMID: 41981854](https://pubmed.ncbi.nlm.nih.gov/41981854/). *J Dermatol*. [Other]
Yu SC (2026). [PMID: 42052902](https://pubmed.ncbi.nlm.nih.gov/42052902/). *J Pathol*. [Basic Science / Preclinical]
AI-curated news mentioning Kikuchi-Fujimoto disease
Updated Oct 6, 2026
A recent study highlights the diagnostic challenges of haemophagocytic lymphohistiocytosis when triggered by Kikuchi-Fujimoto disease. This research underscores the complexity of diagnosing overlapping rare diseases.
A recent study highlights Kikuchi-Fujimoto disease as a potential cause of refractory eyelid lesions that can be mistaken for chalazia. This discovery emphasizes the need for awareness and accurate diagnosis of this rare condition.
A recent study investigates genetic factors in Kikuchi-Fujimoto disease across three generations, providing insights into its hereditary nature. This research may enhance understanding of the disease's pathogenesis and inform future therapeutic strategies.